Literature DB >> 10082263

Ginsenoside Rg3 mediates endothelium-dependent relaxation in response to ginsenosides in rat aorta: role of K+ channels.

N D Kim1, S Y Kang, J H Park, V B Schini-Kerth.   

Abstract

The aim of the present study was to characterize the endothelium-dependent relaxation elicited by ginsenosides, a mixture of saponin extracted from Panax ginseng, in isolated rat aorta. Relaxations elicited by ginsenosides were mimicked by ginsenoside Rg1 and ginsenoside Rg1, two major ginsenosides of the protopanaxatriol group. Ginsenoside Rg3 was about 100-fold more potent than ginsenoside Rg1. The endothelium-dependent relaxation in response to ginsenoside Rg3 was associated with the formation of cycle GMP. These effects were abolished by N(G)-nitro-L-arginine and methylene blue. Relaxations in response to ginsenoside Rg3 were unaffected by atropine, diphenhydramine, [D-Pro2, D-Trp7,9]substance P, propranolol, nifedipine, verapamil and glibenclamide but were markedly reduced by tetraethylammonium. Tetraethylammonium modestly reduced the relaxation induced by sodium nitroprusside. These findings indicate that ginsenoside Rg3 is a major mediator of the endothelium-dependent nitric oxide-mediated relaxation in response to ginsenosides in isolated rat aorta, possibly via activation of tetraethylammonium-sensitive K+ channels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082263     DOI: 10.1016/s0014-2999(98)00898-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  27 in total

1.  Ginsenoside Rb1 attenuates homocysteine-augmented guidewire injury-induced intimal hyperplasia in mice.

Authors:  Hong Chai; Yanlan Dong; Xinwen Wang; Wei Zhou
Journal:  J Surg Res       Date:  2008-08-15       Impact factor: 2.192

Review 2.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 3.  Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

Authors:  Morris Karmazyn; Xiaohong Tracey Gan
Journal:  Mol Cell Biochem       Date:  2020-09-17       Impact factor: 3.396

4.  Endothelium-independent vasorelaxant effect of 20(S)-protopanaxadiol on isolated rat thoracic aorta.

Authors:  Lu Gan; Zhen-Hua Wang; Hong Zhang; Xin Zhou; Hui Zhou; Chao Sun; Jing Si; Rong Zhou; Cheng-Jun Ma; Ji Li
Journal:  Acta Pharmacol Sin       Date:  2016-09-12       Impact factor: 6.150

5.  Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase.

Authors:  Nak Doo Kim; Eun Mi Kim; Keon Wook Kang; Min Kyung Cho; So Yeon Choi; Sang Geon Kim
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

6.  Anti-breast cancer activity of Fine Black ginseng (Panax ginseng Meyer) and ginsenoside Rg5.

Authors:  Shin-Jung Kim; An Keun Kim
Journal:  J Ginseng Res       Date:  2014-10-18       Impact factor: 6.060

7.  Inhibitory Effects of Total Ginseng Saponin on Catecholamine Secretion from the Perfused Adrenal Medulla of SHRs.

Authors:  Seok-Jeong Jang; Hyo-Jeong Lim; Dong-Yoon Lim
Journal:  J Ginseng Res       Date:  2011-06       Impact factor: 6.060

8.  Molecular mechanisms of large-conductance ca (2+) -activated potassium channel activation by ginseng gintonin.

Authors:  S H Choi; B H Lee; S H Hwang; H J Kim; S M Lee; H C Kim; H W Rhim; S Y Nah
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

9.  Changes in the Contents of Prosapogenin in the Red Ginseng (Panax ginseng) Depending on Steaming Batches.

Authors:  Sun A Lee; Hee Kyung Jo; Byung Ok Im; Sungun Kim; Wan Kyun Whang; Sung Kwon Ko
Journal:  J Ginseng Res       Date:  2012-01       Impact factor: 6.060

10.  Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides.

Authors:  Patrick Ying Kit Yue; Nai Ki Mak; Yuen Kit Cheng; Kar Wah Leung; Tzi Bun Ng; David Tai Ping Fan; Hin Wing Yeung; Ricky Ngok Shun Wong
Journal:  Chin Med       Date:  2007-05-15       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.